SecBot SecBot
424B5 ·Filed Apr 2, 2026

ADAG

Adagene Inc.
NEUTRAL
Impact 5/10
Horizonweeks Processed6mo ago SEC0001104659-26-038861
Notable filing: 424B5
Actionable Insight • Neutral

Investors should monitor the final prospectus for the specific number of ADSs being offered and the offering price, as well as the company's ability to comply with regulatory requirements in China, including the CSRC filing and PCAOB inspection issues. The company's status as a potential PFIC could have significant tax implications for U.S. investors, which should be considered in investment decisions.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
ADAG ▲ +5.26% at T+60d
NEUTRAL call +5.26% · α vs SPY -8.90% · entry $3.99 → $4.20
Entry = T+0 close
Apr 2, 2026
via day close
T+1d
+8.27%
call +8.27% · α +7.79%
$4.32
settled 7mo ago
T+5d
-4.76%
call -4.76% · α -8.38%
$3.80
settled 7mo ago
T+20d
-7.77%
call -7.77% · α -17.65%
$3.68
settled 6mo ago
T+60d
+5.26%
call +5.26% · α -8.90%
$4.20
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Adagene Inc. is conducting a preliminary prospectus supplement for a public offering of American Depositary Shares (ADSs) to raise capital. The offering is subject to completion and does not specify the number of ADSs or the offering price. The company intends to use the net proceeds primarily for research and development activities on its pipeline candidates, including ADG126, ADG138, and other programs, and for general corporate purposes. The offering is being managed by Leerink Partners and LifeSci Capital, with Lucid Capital Markets as co-manager. The company faces risks related to its status as a Cayman Islands holding company with operations in China, including regulatory scrutiny, potential delisting due to PCAOB inspection issues, and the need to file with the CSRC post-offering.

Key Facts

  • Adagene Inc. is offering an unspecified number of ADSs, each representing 1.25 ordinary shares.
  • The net proceeds from the offering will be used to fund research and development activities on pipeline candidates, including ADG126, ADG138, and other programs, and for general corporate purposes.
  • The offering is being managed by Leerink Partners and LifeSci Capital, with Lucid Capital Markets as co-manager.
  • The company is subject to risks related to its status as a Cayman Islands holding company with operations in China, including regulatory scrutiny, potential delisting due to PCAOB inspection issues, and the need to file with the CSRC post-offering.
  • The company was likely a passive foreign investment company (PFIC) for 2025 and there is a significant risk it will be a PFIC for 2026, which could have adverse U.S. federal income tax consequences for investors.

Financial Impact

The net proceeds from the offering will be used to fund research and development activities on pipeline candidates, including ADG126, ADG138, and other programs, and for general corporate purposes.

cashdilutionresearch and development expenses

Risk Factors

  • Regulatory risks related to the company's status as a Cayman Islands holding company with operations in China, including potential delisting due to PCAOB inspection issues.
  • The need to file with the CSRC post-offering, which could delay or prevent the offering.
  • The company's status as a potential PFIC, which could have adverse U.S. federal income tax consequences for investors.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001104659-26-038861
Document: 0001104659-26-038861-index-headers.html0001104659-26-038861
Document: 0001104659-26-038861-index.html0001104659-26-038861
Document: 0001104659-26-038861.txt0001104659-26-038861
16 reports for ADAG
Performance horizon
60% Hit rate @ T+60 3 of 5 directional calls Went positive at some point 5 of 7 best @ T+1▲ +8.27%Apr 1, 2026
Filters
Rows
Reports for ADAG — sortable, filterable
TypeNow
Sep 25, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$3.20awaiting T+60—$2.49 (−22.19%)
Sep 22, 2026
4w ago
6-K
BULLISH ★ 5/10
$3.23awaiting T+60—$2.49 (−22.91%)
Sep 10, 2026
6w ago
6-K
BULLISH ★ 5/10
$3.31awaiting T+60—$2.49 (−24.77%)
Sep 9, 2026
6w ago
6-K
NEUTRAL ★ 3/10
$3.27awaiting T+60—$2.49 (−23.85%)
Aug 16, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$3.83awaiting T+60—$2.49 (−34.99%)
Aug 12, 2026
10w ago
6-K
NEUTRAL ★ 5/10
$3.75awaiting T+60—$2.49 (−33.60%)
Aug 12, 2026
10w ago
Press Release
MIXED ★ 6/10
$3.75awaiting T+60—$2.49 (−33.60%)
Jul 6, 2026
16w ago
6-K
NEUTRAL ★ 3/10
$3.93 $3.21▼ −18.32%▼ −20.04%$2.49 (−36.64%)
Apr 17, 2026
27w ago
6-K
BULLISH ★ 8/10
$3.89 $3.67▼ −5.66%▼ −12.43%$2.49 (−35.99%)
Apr 2, 2026
29w ago
6-K
BEARISH ★ 7/10
$3.99 $4.20▼ −5.26%▲ +8.90%$2.49 (+37.59%)
Showing 10 of 16

US Market Status

Market Closed — Opens Tue (15h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 2, 2026